Square Pharma gets US FDA approval

The US Food and Drug Administration (FDA) has recently given its approval to Square Pharmaceuticals after inspecting the oral solid dosage facilities of the company in Bangladesh, says a press release.
On June 16, the FDA released its Establishment Inspection Report under which it was audited whether the firm is following the current good manufacturing practices.
The approval is given based on the comprehensive audit on all the systems of drug manufacturing: quality, facilities and equipment, materials, production, packaging and labelling and laboratory controls, according to the statement.
The inspections ended without issuing any 483 form. A 483 form is issued when the FDA has observations of non-compliance or deviation from good manufacturing practices.

 

Square Pharma gets US FDA approval

The US Food and Drug Administration (FDA) has recently given its approval to Square Pharmaceuticals after inspecting the oral solid dosage facilities of the company in Bangladesh, says a press release. On June 16, the FDA released its Establishment Inspection Report under which it was audited whether the firm is following the current good manufacturing practices. The approval is given based on the comprehensive audit on all the systems of drug manufacturing: quality, facilities and equipment, materials, production, packaging and labelling and laboratory controls, according to the statement. The inspections ended without issuing any 483 form. A 483 form is issued when the FDA has observations of non-compliance or deviation from good manufacturing practices.